FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.

Read at NBC News(opens in a new tab)
Full coverage
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness (opens NBC News in a new tab)
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
